TY - JOUR
T1 - Long-term outcomes of treatments for achalasia
AU - Nullens, Sara
AU - Fockens, Paul
AU - Bredenoord, Albert J.
N1 - Publisher Copyright: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2021/7/1
Y1 - 2021/7/1
N2 - PURPOSE OF REVIEW: Idiopathic achalasia is a primary motility disorder of the esophagus that results in dysphagia, weight loss, and impaired quality of life. Several treatment options are available to gastroenterologists, and insights on the long-term outcome of these modalities are discussed. RECENT FINDINGS: Peroral endoscopic myotomy (POEM) represents a novel endoscopic technique in the treatment of achalasia. Studies on long-term outcomes and comparison to other well-known treatment modalities such as laparoscopic Heller myotomy (LHM) and pneumodilation have recently been published. POEM and LHM both have excellent 2-year success rates for relieving achalasia symptoms, but reflux disease and erosive esophagitis are more prevalent following POEM. SUMMARY: Several treatment modalities with excellent long-term outcomes are available for the treatment of achalasia. The different options should be discussed with patients and treatments should be tailored to their individual needs.
AB - PURPOSE OF REVIEW: Idiopathic achalasia is a primary motility disorder of the esophagus that results in dysphagia, weight loss, and impaired quality of life. Several treatment options are available to gastroenterologists, and insights on the long-term outcome of these modalities are discussed. RECENT FINDINGS: Peroral endoscopic myotomy (POEM) represents a novel endoscopic technique in the treatment of achalasia. Studies on long-term outcomes and comparison to other well-known treatment modalities such as laparoscopic Heller myotomy (LHM) and pneumodilation have recently been published. POEM and LHM both have excellent 2-year success rates for relieving achalasia symptoms, but reflux disease and erosive esophagitis are more prevalent following POEM. SUMMARY: Several treatment modalities with excellent long-term outcomes are available for the treatment of achalasia. The different options should be discussed with patients and treatments should be tailored to their individual needs.
UR - http://www.scopus.com/inward/record.url?scp=85107390394&partnerID=8YFLogxK
U2 - https://doi.org/10.1097/MOG.0000000000000744
DO - https://doi.org/10.1097/MOG.0000000000000744
M3 - Review article
C2 - 33859101
SN - 0267-1379
VL - 37
SP - 408
EP - 413
JO - Current opinion in gastroenterology
JF - Current opinion in gastroenterology
IS - 4
ER -